Comprehensive Evaluation of Commercial Antibodies for High Sensitivity Detection of EPO-Doping on Western Blots.

Reichel C, Gmeiner G, Geyer H, Thevis M

DOI: 10.1002/dta.70152
Published: 2026 Sep 23
Container: Drug testing and analysis
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/dta.70152,
  title = {Comprehensive Evaluation of Commercial Antibodies for High Sensitivity Detection of EPO-Doping on Western Blots.},
  author = {Reichel C and Gmeiner G and Geyer H and Thevis M},
  year = {2026},
  journal = {Drug testing and analysis},
  doi = {10.1002/dta.70152},
  url = {https://doi.org/10.1002/dta.70152}
}

RIS

TY  - JOUR
TI  - Comprehensive Evaluation of Commercial Antibodies for High Sensitivity Detection of EPO-Doping on Western Blots.
AU  - Reichel C
AU  - Gmeiner G
AU  - Geyer H
AU  - Thevis M
PY  - 2026
JO  - Drug testing and analysis
DO  - 10.1002/dta.70152
UR  - https://doi.org/10.1002/dta.70152
ER  -

APA

C, R., G, G., H, G., & M, T. (2026). Comprehensive Evaluation of Commercial Antibodies for High Sensitivity Detection of EPO-Doping on Western Blots.. Drug testing and analysis. https://doi.org/10.1002/dta.70152

Source records

pubmed · retrieved 2026-09-24T23:43:35.614Z